BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 2544313)

  • 21. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
    Fischer SM; Jasheway DW; Klann RC; Butler AP; Patrick KE; Baldwin JK; Cameron GS
    Cancer Res; 1989 Dec; 49(23):6693-9. PubMed ID: 2819717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cells.
    Nakadate T; Yamamoto S; Aizu E; Nishikawa K; Kato R
    Mol Pharmacol; 1989 Dec; 36(6):917-24. PubMed ID: 2601687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. sn-1,2-Diacylglycerols mimic the effects of 12-O-tetradecanoylphorbol-13-acetate in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis.
    Smart RC; Huang MT; Conney AH
    Carcinogenesis; 1986 Nov; 7(11):1865-70. PubMed ID: 3769135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Cancer Res; 1986 Apr; 46(4 Pt 1):1589-93. PubMed ID: 3081251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea.
    Katiyar SK; Agarwal R; Wood GS; Mukhtar H
    Cancer Res; 1992 Dec; 52(24):6890-7. PubMed ID: 1458478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3'-Hydroxypterostilbene Inhibits 7,12-Dimethylbenz[a]anthracene (DMBA)/12-O-Tetradecanoylphorbol-13-Acetate (TPA)-Induced Mouse Skin Carcinogenesis.
    Lee PS; Chiou YS; Chou PY; Nagabhushanam K; Ho CT; Pan MH
    Phytomedicine; 2021 Jan; 81():153432. PubMed ID: 33310310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
    Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
    Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro.
    Dlugosz AA; Yuspa SH
    Cancer Res; 1991 Sep; 51(17):4677-84. PubMed ID: 1678684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Gan; 1984 Mar; 75(3):214-22. PubMed ID: 6427052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis.
    Sharma M; Mohapatra J; Argade A; Deshpande SS; Shah GB; Chatterjee A; Jain MR
    Immunopharmacol Immunotoxicol; 2014 Aug; 36(4):282-9. PubMed ID: 24946851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate.
    Huang MT; Smart RC; Wong CQ; Conney AH
    Cancer Res; 1988 Nov; 48(21):5941-6. PubMed ID: 3139287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.
    Chida K; Murakami A; Tagawa T; Ikuta T; Kuroki T
    Cancer Res; 1995 Nov; 55(21):4865-9. PubMed ID: 7585521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis.
    Chaudhary SC; Alam MS; Siddiqui MS; Athar M
    Life Sci; 2009 Jul; 85(5-6):196-205. PubMed ID: 19470390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin.
    Huang MT; Ho CT; Wang ZY; Ferraro T; Finnegan-Olive T; Lou YR; Mitchell JM; Laskin JD; Newmark H; Yang CS
    Carcinogenesis; 1992 Jun; 13(6):947-54. PubMed ID: 1600615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.
    Skarin T; Rozell BL; Bergman J; Toftgård R; Möller L
    Chem Biol Interact; 1999 Sep; 122(2):89-106. PubMed ID: 10528995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors.
    Chiou YS; Sang S; Cheng KH; Ho CT; Wang YJ; Pan MH
    Carcinogenesis; 2013 Jun; 34(6):1315-22. PubMed ID: 23385063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice.
    Saleem M; Afaq F; Adhami VM; Mukhtar H
    Oncogene; 2004 Jul; 23(30):5203-14. PubMed ID: 15122342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.